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Introduction {#s1}
============

Manganese (Mn), an abundant element on Earth, is an essential micronutrient for animals and humans and functions as a cofactor in several important biological processes during development, including bone formation, protein and energy metabolism, and metabolic regulation ([@c1]; [@c18]; [@c57]). However, Mn is also a potential toxicant for humans at excessive exposure levels ([@c13]). Environmental Mn occurs naturally and is also released into the atmosphere, waterways, and soil from industrial activities such as mining and metal smelting ([@c1]; [@c25]). Mn is widely used in manufacturing a variety of products, including cosmetics, fertilizer, paints, fireworks, and additive agents in steel production and gasoline ([@c1]). The general population is exposed to Mn mainly through diet, but additional amounts of Mn, usually from the environment, can also enter the human body via the respiratory system and skin contact ([@c1]).

The fetal period is particularly sensitive to environmental threats ([@c3]). Exposure to environmental toxicants during the fetal period have been related to not only restricted fetal growth and development ([@c10]; [@c29], [@c28]; [@c31]; [@c34]; [@c36]; [@c42]; [@c58]; [@c59]) but also long-term health challenges ([@c14]; [@c20]; [@c56]). Moreover, identifying critical windows of susceptibility to environmental pollutants exposure during pregnancy is essential for infants' and children's health because exposures during such time periods may be associated with stronger health effects ([@c46]). Mn crosses the placental barrier through active transport mechanisms ([@c33]). Animal studies have linked both gestational Mn deficiency and overexposure to decreased fetal size ([@c4]; [@c12]; [@c47]; [@c53]). Moreover, mice and rats are sensitive to Mn-related fetotoxicities, including reduced fetal body weight and increased risk of skeleton malformation, during mid (days 9--10) and late gestation (days 15--17) ([@c12]; [@c53]).

In humans, Mn deficiency is rare because the required amount of Mn can be provided through dietary intake ([@c16]). However, excessive exposure to Mn during pregnancy has been related to impaired neurological development ([@c5]; [@c39]). A recent study of the general Chinese population suggested that the Mn exposure level in women was nearly 30% higher than in men ([@c60]). In addition, one of our previous studies suggested that exposure to higher levels of Mn, even at levels that did not exceed the upper limit of urinary reference ($10\;\mu g/L$) ([@c38]), was associated with an increased risk of low birth weight ([@c58]). Moreover, a few studies suggested parabolic dose--response relationships between Mn exposure during pregnancy and size at birth, but most of these findings were based on one-time exposure assessments ([@c9]; [@c19]; [@c22]; [@c40]; [@c54]; [@c58]; [@c62]). Only two studies, to our knowledge, have investigated trimester-specific associations of Mn exposure during pregnancy with birth outcomes in humans and had limited sample sizes ([@c40]; [@c54]).

Based on a Chinese prospective prenatal cohort of 3,022 women, this study aimed to assess trimester-specific associations of exposure to Mn during pregnancy with size at birth as well as to identify the critical window of heightened susceptibility of Mn exposure.

Methods {#s2}
=======

Study Population {#s2.1}
----------------

This study was carried out based on our ongoing prospective prenatal cohort study that was launched in October 2013 at the Wuhan Women and Children Medical Care Center, the municipal health center for women and children in Wuhan, Hubei Province, China. A pregnant woman was eligible if she *a*) agreed to provide signed informed consent; *b*) was less than 16-weeks pregnant with a single gestation at the time of enrollment; *c*) was a resident of Wuhan and knew Chinese; *d*) agreed to complete in-person interviews, undergo ultrasound examinations, and provide blood and urine samples at government-recommended prenatal care visits; and *e*) was willing to give birth at the study hospital. Between October 2013 and October 2016, 3,075 women who provided at least one urine sample, did not smoke tobacco during pregnancy, and gave birth to live singletons without birth defects were included. After additionally excluding 53 women with missing data of confounding variables, 3,022 women were retained in this study. The study protocol was reviewed and approved by the ethics committees of Tongji Medical College, Huazhong University of Science and Technology \[No. (2012)07\] and the Wuhan Women and Children Medical Care Center \[No. 2010009\].

Urine Collection and Analysis {#s2.2}
-----------------------------

Maternal urine samples \[$\text{mean} \pm \text{standard}\,\text{deviation}$ (SD)\] were obtained at three government-recommended prenatal care visits in the first ($13.0 \pm 1.0$ weeks, the first prenatal care visit), second ($23.3 \pm 2.3$ weeks), and third ($37.9 \pm 1.8$ weeks) trimesters. Of all the study population, 823 (27.2%) women provided one urine sample, 1,342 (44.4%) women provided two urine samples, and 857 (28.4%) women provided three urine samples. It is noteworthy that 2,252 (81.3%) of all the first-trimester urine samples ($n = 2,771$) were obtained at or before 13 weeks of gestation. Women with missing urine samples either rejected providing one, missed their prenatal care visits, or went into early labor before the third-trimester urine sample was collected. Prior to assessments, all urine samples were stored in polypropylene cups at $- 20{^\circ}C$ for a median of 46.1 (interquartile range: 36.1--57.4) weeks for first-trimester samples, 35.6 (25.4--46.4) weeks for second-trimester samples, and 26.4 (16.6--36.6) weeks for third-trimester samples. The temperature of all refrigerators was monitored weekly to ensure the condition of sample storage.

We used an inductively coupled plasma mass spectrometry (ICP-MS; Agilent 7,700, Agilent Technologies) to measure urinary concentrations of Mn and other toxic metals that have been related to restricted fetal growth or size at birth in previous studies, including vanadium (V), arsenic (As), cadmium (Cd), and lead (Pb) ([@c10]; [@c29], [@c28]; [@c31]; [@c36]; [@c59]). Detailed descriptions for sample preparation, assessment, ICP-MS operating condition, and quality controls have been provided previously ([@c10]). Briefly, urine samples were thawed at room temperature, nitrated overnight using 3% $\text{HNO}_{3}$, and sonicated by ultrasound at 40°C for 1 h. Before being assessed by the ICP-MS, supernatants were obtained after centrifuging the resulting samples; then $$, $$, $$, $$, and $$ were monitored in helium mode. The detection limit of quantification (LOQ) of each metal was calculated as $\text{LOQ} = 10 \times \text{LOD}/3$. The LOD (limit of detection) was calculated as $\text{LOD} = 3 \times \text{RSD}_{b} \times C/\text{SBR}$, where $\text{RSD}_{b}$ represents the relative standard deviation for 11 measurements of the background intensity, *C* stands for the concentration of certain metals in the solution, and SBR is the signal-to-background ratio ([@c6]). The LOQs were $0.150\;\mu g/L$ for Mn, $0.008\;\mu g/L$ for V, $0.060\;\mu g/L$ for As, $0.003\;\mu g/L$ for Cd, and $0.023\;\mu g/L$ for Pb. The detection rates of all these metals were higher than 97%. All available urine samples from each woman were prepared and assessed in one batch. Quality control samples were embedded in each batch and were measured in duplicate. In addition, we used the Standard Reference Material Human Urine (SRM2670a; National Institute of Standards and Technology) as an external quality control, and the spike--recoveries of Mn and other toxic metals ranged from 98.8% to 106.4%. We also evaluated measurement variations of all these metals by measuring quality control samples repeatedly. The intraday variations were between 0.29% and 0.89%, and the interday variations were ranged from 0.27% to 0.98% (see Table S1).

Urinary specific gravity (SG) was analyzed by a refractometer (Atago PAL-3; Atago) at room temperature. Before each assessment, the refractometer was calibrated with deionized water.

Size at Birth {#s2.3}
-------------

At the time of delivery, birth weight (in grams) and birth length (in centimeters) were measured and recorded by trained nurses in the study hospital under clinical criteria. Ponderal index (in kilograms per cubic meter) was calculated as $1,000 \times {\text{birth}\,\text{weight}/\text{birth}\,\text{length}}^{3}$ and was considered an indicator of asymmetrical intrauterine growth retardation ([@c35]). Gestational age at birth was calculated as days between the date of delivery and the first day of the last menstrual period (LMP). The dates of LMP were reported by pregnant women and were then corrected by obstetricians using the first-trimester ultrasound measures under clinical criteria. For women who provided accurate dates of the LMP, corrected gestational ages were used if the difference between the reported and corrected gestational ages was $> 7\; d$. A term birth was defined as a childbirth occurring after 37 weeks of gestation.

We constructed gestational age--adjusted standard deviation scores (SD-scores) for birth size parameters using the GAMLSS package (version 4.3-7) in R (version 3.3.2; R Development Core Team). These SD-scores represent the percentiles of weight, length, or ponderal index at birth. The calculation was based on an assumption that the distributions of these parameters depend only on gestational age. We used Box-Cox transformations to normalize these parameters ([@c43]). Then, we modeled each parameter using a cubic spline of gestational age in days. Finally, gestational age--adjusted SD-scores for birth weight, birth length, and ponderal index were generated based on the best fitting models, which were selected according to the Akaike's information criteria.

Covariates {#s2.4}
----------

Trained nurses used standardized and structured questionnaires during in-person interviews at the first prenatal care visits to collect the information on maternal age, education, tobacco smoking, passive smoking, alcohol consumption, folic acid supplementation, physical activity during pregnancy, and paternal height and weight. Maternal prepregnancy and paternal body mass index (BMI; kilograms per cubic meter) were subsequently calculated. Gynecological and obstetrical information (e.g., parity, anemia, hypertensive disorders of pregnancy, gestational diabetes mellitus, and infant sex) was retrieved from medical records. In order to ensure accuracy and reliability, we carried out scheduled and standardized quality controls for the data used in this study.

Statistical Analysis {#s2.5}
--------------------

Urinary metal concentrations (micrograms per liter) below the LOQ for each metal were imputed with LOQs divided by the square root of 2. Urinary concentrations of Mn and other toxic metals were adjusted by urinary SG using: $P_{c} = P\left\lbrack {\left( {1.011–1} \right)/\left( {\text{SG}–1} \right)} \right\rbrack$, where $P_{c}$ represents the SG-adjusted concentration, *P* represents the unadjusted concentration, 1.011 is the median SG of all measured urine samples, and SG represents the individual urinary specific gravity ([@c15]). Both SG-adjusted and -unadjusted concentrations were transformed by natural logarithm (ln) to reduce the influence of outliers.

Pearson correlation coefficients for urinary concentrations of Mn and other toxic metals in each trimester were calculated based on ln-transformed concentrations. In order to estimate their temporal variabilities, we used mixed-effects models to calculate intraclass correlation coefficients (ICCs) and 95% confident intervals (CIs) of urinary SG and urinary Mn concentrations. The ICC, ranging from 0 (no reproducibility) to 1 (perfect reproducibility), is the ratio of between-subject variance to total variance and which evaluates the reproducibility of a biomarker in a population over time ([@c45]).

We applied a multiple informant model to test trimester-specific associations between urinary Mn concentrations during pregnancy and size at birth ([@c46]). The multiple informant model treats Mn concentrations at different time windows as informants, using linear regressions with generalized estimating equations to estimate associations of each individual Mn concentration with a given outcome simultaneously in the same statistical model. In addition, this multiple informant model does not adjust for exposures in other time windows but instead tests the null hypothesis that the associations of Mn concentrations are equal at each time window versus the alternative hypothesis that at least one association differs from the rest. We used the multiple informant model to estimate the trimester-specific associations of quintiles of urinary Mn concentrations (as categorical variables, the mid-quintiles were set as the references) in the first, second, and third trimesters with birth weight, birth length, and ponderal index. Trimester-specific quintiles were generated based on urinary Mn concentrations in each trimester.

We also used the method described by Sánchez et al. ([@c46]) for additional analysis. This method, based on linear mixed models, compares the prenatal exposure pattern of newborns with restricted size at birth to those without in order to evaluate which period of pregnancy might be the critical window of heightened susceptibility to Mn exposure. Specifically, we used this method to compare the pattern of urinary ln-Mn during pregnancy for newborns with low SD-scores (in the 10th percentiles) for birth weight, birth length, or ponderal index to those with high SD-scores (in the 90th percentiles).

All the statistical models were adjusted for potential confounders, including gestational age at the time of delivery (continuous), maternal age at recruitment (continuous), parity (nulliparous/multiparous), maternal prepregnancy BMI (categorized based on the Chinese standard: $< 18.5/18.5–23.9/ \geq 24.0{\,{kg}/m}^{2}$), alcohol consumption before pregnancy (no/yes), active smoking before pregnancy (no/yes), passive smoking during pregnancy (no/yes), education ($\leq 9/9–12/ > 12\; y$), folic acid supplementation (no/only in the first trimester/only in the second and third trimester/during the entire pregnancy), physical activity during pregnancy (no/1--4/5--7 d/week), and infant sex (boy/girl). Models for birth length were also adjusted for maternal and paternal height (continuous). In order to test the potential impact of pregnancy complications, models were additionally adjusted for anemia (no/yes), gestational diabetes mellitus (no/yes), and hypertensive disorders of pregnancy (no/hypertension/preeclampsia).

Stratified analyses were conducted to test potential differences between boys and girls and between younger ($\leq 27\; y$ old at recruitment) and older ($> 27\; y$ old at recruitment) women. Stratum-specific *p*-values for interaction were estimated as the *p*-values for the interaction terms of infant sex (or maternal age) and each quintile of urinary Mn concentrations. As a sensitivity analysis to examine the impact of premature deliveries, we replicated all the models restricted to term births. Another sensitivity analysis was conducted to determine whether there was residual confounding from correlated metal exposures and whether the observed associations in this study were false positives by replicating regression models with additional adjustment for other toxic metals (V, As, Cd, and Pb) that have been related to restricted fetal growth or size at birth ([@c10]; [@c29], [@c28]; [@c31]; [@c36]; [@c59]). In the third sensitivity analysis, we replicated regression models restricted to women without anemia, gestational diabetes mellitus, or hypertensive disorders of pregnancy in order to evaluate the impact of maternal pregnancy complications. Finally, we replicated regression models *a*) restricted to women who provided three urine samples to evaluate the potential misclassification caused by missing of urine samples, *b*) using unadjusted concentrations in regression models to assess the potential misclassification caused by urine dilution, and *c*) using the quintile of Mn concentration that was generated based on all measurements to estimate the potential misclassification caused by variations of urinary Mn concentrations throughout the whole pregnancy.

All statistical analyses were performed using R (version 3.3.2) or SAS (version 9.4; SAS Institute, Inc.). The statistical significance level was 0.05 for a two-tailed test.

Results {#s3}
=======

Of all the 3,022 women in this study, 2,923 gave birth at term. Women recruited in this study were on average of $27.8 \pm 3.4$ y of age, and most of them were nulliparous (85.4%), nonsmokers (99.4%), and nondrinkers (99.2%). Before pregnancy, 575 (19.0%) women were underweight ($\text{BMI} < 18.5{\,{kg}/m}^{2}$), 323 (10.7%) were overweight (BMI between 24.0 and $27.9{\,{kg}/m}^{2}$), and only 65 (2.2%) were obese ($\text{BMI} \geq 28.0{\,{kg}/m}^{2}$). Most of the women had at least a college-level education (78.6%), used folic acid supplementations during pregnancy (83.5%), or exercised at least 5 d a week during pregnancy (75.1%). In addition, approximately 52.7% of the newborns were boys ([Table 1](#t1){ref-type="table"}). The distributions of maternal, paternal, and neonatal baseline characteristics for term births were similar to those for the whole population (see Table S2).

###### 

Characteristics of parents and children in the study population (Wuhan, China).

Table 1 lists characteristics of the population in the first column; the corresponding N (percentage) values or mean plus or minus SD values are listed in the second column.

  Characteristic                            $n$ (%) or $\text{mean} \pm \text{SD}$
  ---------------------------------------- ----------------------------------------
  All individuals                                           3,022
  Maternal characteristics                                     
   Age at recruitment (y)                              $27.83 \pm 3.40$
    $< 25$                                               398 (13.17)
    25--30                                              1,833 (60.66)
    30--35                                               655 (21.67)
    $\geq 35$                                             136 (4.50)
   Prepregnancy BMI (${{kg}/m}^{2}$)                   $20.86 \pm 2.84$
    $< 18.5$                                             575 (19.03)
    18.5--23.9                                          2,059 (68.13)
    24.0--27.9                                           323 (10.69)
    $\geq 28.0$                                           65 (2.15)
   Height (m)                                          $1.61 \pm 0.05$
   Parity                                                      
    Nulliparous                                         2,580 (85.37)
    Multiparous                                          442 (14.63)
   Anemia during pregnancy                                     
    No                                                  3,003 (99.37)
    Yes                                                   19 (0.63)
   Hypertensive disorders of pregnancy                         
    No                                                  2,926 (96.82)
    Hypertension                                          63 (2.08)
    Preeclampsia                                          33 (1.09)
   Gestational diabetes mellitus                               
    No                                                  2,760 (91.33)
    Yes                                                   262 (8.67)
   Active smoking before pregnancy                             
    No                                                  3,003 (99.37)
    Yes                                                   19 (0.63)
   Passive smoking during pregnancy                            
    No                                                  2,142 (70.88)
    Yes                                                  880 (29.12)
   Alcohol consumption before pregnancy                        
    No                                                  2,997 (99.17)
    Yes                                                   25 (0.83)
   Education                                                   
    Compulsory and lower ($\leq 9\; y$)                   194 (6.42)
    High school and equivalent (9--12 y)                 453 (14.99)
    Graduate and higher ($> 12\; y$)                    2,375 (78.59)
   Folic acid supplementation                                  
    No                                                   499 (16.51)
    Only in the 1st trimester                           1,047 (34.65)
    Only in the 2nd and 3rd trimester                    620 (20.52)
    During the entire pregnancy                          856 (28.33)
   Physical activity during pregnancy                          
    No                                                    278 (9.20)
    1--4 d/week                                          476 (15.75)
    5--7 d/week                                         2,268 (75.05)
  Paternal height (m)                                  $1.74 \pm 0.05$
  Neonatal characteristics                                     
   Infant sex                                                  
    Male infant                                         1,594 (52.75)
    Female infant                                       1,428 (47.25)
   Gestational age (weeks)                             $39.29 \pm 1.19$
   Birth weight (g)                                 $3,326.24 \pm 429.60$
   Birth length (cm)                                   $50.27 \pm 1.64$
   Ponderal index (${{kg}/m}^{3}$)                     $26.08 \pm 2.11$

Note: BMI, body mass index; SD, standard deviation.

The geometric mean of SG-adjusted urinary Mn concentrations in all urine samples was $1.46\;\mu g/L$ (95% CI: 1.42, 1.50) and the median was $1.41\;\mu g/L$ (95% CI: 1.37, 1.45; see Table S1). Urinary Mn concentrations of the study population were compared with those of other populations ([Table 2](#t2){ref-type="table"}). Pearson correlation coefficients of urinary Mn concentrations and other toxic metals were between 0.07 and 0.57 (see Table S3). The ICC (95% CI) of SG-adjusted urinary ln-Mn was 0.32 (95% CI: 0.29, 0.35) in all urine samples, indicating a poor reproducibility throughout the whole pregnancy. The ICC in the first and third trimesters ($\text{ICC}_{13} = 0.29$, 95% CI: 0.25, 0.34) was lower than that in the first and second trimesters ($\text{ICC}_{12} = 0.33$, 95% CI: 0.29, 0.38), as well as that in the second and third trimesters ($\text{ICC}_{23} = 0.34$, 95% CI: 0.29, 0.40). In addition, the reproducibility of unadjusted urinary ln-Mn in all urine samples \[$\text{ICC} = 0.39$ (95% CI: 0.36, 0.42)\] was slightly higher than SG-adjusted concentrations. Compared with urinary ln-Mn, urinary SG \[$\text{ICC}_{\text{SG}} = 0.16$ (95% CI: 0.13, 0.20)\] had a poorer reproducibility throughout the whole pregnancy.

###### 

The distributions of urinary Mn concentrations ($\mu g/L$) during pregnancy.

Table 2 lists population and location in the first column. The corresponding information for urine samples and sample size and values for arithmetic mean, geometric mean, and percentiles (5th, 25th, 50th, 75th, and 95th) for urine Mn concentration are listed in the other columns.

  Population and location                                                                                                                                       Urine samples                                       Sample size (*n*)    Urine Mn concentration ($\mu g/L$)                                                 
  ------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------- ------------------- ------------------------------------ ---------- ---------- ---------- ------ ------ ------
  Present study: Pregnant women in an urban city in Hubei, China, 2013--2016; mean 27.8 y of age (18--44 y)                                                     Spot, 13.0 weeks                                    2,771                               2.55                    1.44       0.33       0.80     1.45   2.57   6.19
  Spot, 23.3 weeks                                                                                                                                              1,481                                               2.01                                1.21                    0.27       0.72       1.16     2.03   5.18  
  Spot, 37.8 weeks                                                                                                                                              1,826                                               2.50                                1.47                    0.31       0.82       1.47     2.69   7.17  
  Spot, 13.0 weeks (SG adjusted)                                                                                                                                2,771                                               2.89                                1.38                    0.26       0.68       1.35     2.65   9.89  
  Spot, 23.3 weeks (SG adjusted)                                                                                                                                1,481                                               2.72                                1.38                    0.28       0.70       1.29     2.57   8.24  
  Spot, 37.8 weeks (SG adjusted)                                                                                                                                1,826                                               3.69                                1.66                    0.28       0.83       1.63     3.08   11.5  
  Xia et al. ([@c58]): Pregnant women in urban and rural cities in Hubei, China, 2012--2014; mean 28.1 y of age (17--42 y)                                      Spot, hospital admission for delivery               816                                 0.66                    ---      $< 0.05$     0.13     0.38   0.85   ---
  Callan et al. ([@c7]): Pregnant women in western Australia, 2008--2011; mean 32.0 y of age (19--44 y)                                                         First morning void, 2 weeks prior to delivery       173                                 1.00                    ---        0.10       ---      0.33   ---    3.23
  Gunier et al. ([@c23]): Pregnant women in an agricultural community in California, 1999--2000; $\geq 18\; y\,\text{of}\,\text{age}$ (70% $< 30\; y$ of age)   Spot, 26 weeks                                      59                                  ---                     0.50       ---        0.20     0.40   0.60   ---
  Ljung et al. ([@c37]): Pregnant women in a poor rural subdistrict in Bangladeshi, 2002; mean 27.0 y of age (14--44 y)                                         Spot, 14 weeks                                      388                                 2.50                    ---        ---        0.90     1.60   2.80   ---
  CDC ([@c8]): U.S. residents (NHANES study), 2011--2012                                                                                                        Spot, females $\geq 6\; y\,\text{of}\,\text{age}$   1,242                               ---                     0.13       ---        ---      0.12   0.21   0.41
  Spot, nonsmokers 20--49 y of age                                                                                                                              671                                                 ---                                 0.12                    ---        ---        0.11     0.19   0.36  
  Spot, nonsmoking women $\geq 20\; y\,\text{of}\,\text{age}$                                                                                                   708                                                 ---                                 0.12                    ---        ---        0.12     0.20   0.36  
  Health Canada ([@c26]): Canadian women (CHMS), 2007--2009                                                                                                     Spot, 6--79 y of age                                2,792                               0.15                    0.08     $< 0.05$   $< 0.05$   0.09   0.17   0.41
  Spot, 20--39y of age                                                                                                                                          643                                                 0.13                                0.08                  $< 0.05$   $< 0.05$     0.08     0.17   0.40  
  Spot, 40--59y of age                                                                                                                                          643                                                 0.15                                0.08                  $< 0.05$   $< 0.05$     0.09     0.16   0.40  
  Ohashi et al ([@c41]): Women in Japan, 2000--2005; mean 47.5 y of age (20--81 y)                                                                              Spot                                                1,000                               ---                     0.14       ---        ---      0.16   ---    ---
  Spot (SG adjusted)                                                                                                                                            1,000                                               ---                                 0.12                    ---        ---        0.12     ---    ---   
  Goullé et al. ([@c21]): Men and women in France (age and year not specified)                                                                                  Spot                                                100                                 ---                     ---        0.11       ---      0.31   ---    1.32
  Heitland and Köster ([@c27]): Men and women in Germany, 2005; 18--65 y of age                                                                                 Morning middle-stream                               87                                  0.09                    0.06       ---        ---      ---    ---    0.21

Note: AM, arithmetic mean; CHMS, Canadian Health Measures Survey; GM, Geometric mean; NHANES, National Health and Nutrition Examination Survey; SG, specific gravity.

In multivariable analyses, we did not observe any association of urinary Mn concentration in the first trimester with size at birth. When comparing higher quintiles to the third quintile of urinary Mn concentrations in the second and third trimesters, we observed significant reductions in birth weight, birth length, and ponderal index \[e.g., for women who were in the fourth and fifth quintiles of Mn concentrations in the third trimester, the reduction in birth weight was $- 21.2$ (95% CI: $- 35.0$, $- 7.5$) g and $- 11.2$ (95% CI: $- 22.2$, $- 0.1$) g, respectively, and the reduction in birth length was $- 0.08$ (95% CI: $- 0.13$, $- 0.03$) cm and $- 0.04$ (95% CI: $- 0.08$, 0.00) cm, respectively\]; whereas nonsignificant reductions in birth weight, birth length, and ponderal index were observed when comparing lower quintiles of Mn concentrations ([Figure 1](#f1){ref-type="fig"}; see also Table S4). Of note, when restricting the analysis to term births, the associations of urinary Mn concentrations in different trimesters with size at birth were similar with those observed in all participants (see Table S5). Further adjusting for pregnancy complications or other toxic metals (see Table S4), or limiting the analysis to women without pregnancy complications (see Table S6) yielded generally similar findings. In addition, compared with the main results, the observed associations were slightly attenuated when restricting the analysis to women who provided three urine samples (see Table S7), categorizing quintiles of urinary Mn concentration by pooling measurements from all trimesters (see Table S8), or using unadjusted urinary Mn concentrations (see Table S9). However, association directions remained consistent with the main results.

![Adjusted associations of specific gravity (SG)--adjusted urinary Mn concentrations ($\mu g/L$) during pregnancy with size at birth. Regression coefficients ($\beta s$) and 95% confidence intervals (CIs) for associations of SG-adjusted urinary Mn concentrations during pregnancy with (*A*) birth weight, (*B*) birth length, and (*C*) ponderal index were estimated using linear regressions with generalized estimating equations. Models were adjusted for gestational age at delivery, maternal age at recruitment, parity, prepregnancy body mass index, alcohol consumption before pregnancy, active smoking before pregnancy, passive smoking during pregnancy, education, folic acid supplementation, physical activity during pregnancy, and infant sex. The model for birth length model was additionally adjusted for maternal and paternal height. Numeric data are available in Table S4.](ehp-126-127006-g0001){#f1}

In stratified analyses ([Figure 2](#f2){ref-type="fig"}; see also Table S10), infant sex-based differences in associations between urinary Mn concentrations and size at birth were generally nonsignificant ($p\,\text{for}\,\text{interaction} > 0.05$). Most of the associations observed in boys were similar to those observed in girls; however, some were in the opposite directions \[e.g., when comparing the second quintile to the third quintile of urinary Mn concentrations in the third trimester, the ponderal index for boys reduced by $- 0.20$ (95% CI: $- 0.39$, $- 0.01$) ${{kg}/m}^{3}$, but the ponderal index for girls increased by 0.13 (95% CI: $- 0.10$, 0.37) ${{kg}/m}^{3}$, $p\,\text{for}\,\text{interaction} > 0.0210$\]. Otherwise, when stratified by maternal age at recruitment, we did not observe age-based differences in associations between urinary Mn concentrations and size at birth.

![Adjusted associations of specific gravity (SG)--adjusted urinary Mn concentrations ($\mu g/L$) during pregnancy with size at birth, stratified by infant sex and maternal age at recruitment. Regression coefficients ($\beta s$) and 95% confidence intervals (CIs) for associations of SG-adjusted urinary Mn concentrations during pregnancy with (*A,B*) birth weight, (*C,D*) birth length, and (*E,F*) ponderal index were estimated by applying linear regressions with generalized estimating equations and were stratified by infant sex (*A*,*C*,*E*) or maternal age at recruitment (*B*,*D*,*F*). Models were adjusted for gestational age at delivery, maternal age at recruitment, parity, prepregnancy body mass index, alcohol consumption before pregnancy, active smoking before pregnancy, passive smoking during pregnancy, education, folic acid supplementation, physical activity during pregnancy, and infant sex. Models for birth length model were additionally adjusted for maternal and paternal height. Stratum-specific *p*-values for interaction were estimated as the *p*-values for the interaction terms of infant sex (or maternal age) and each quintile of urinary Mn concentrations. Numeric data, including stratum-specific *p*-values for interaction, are available in Table S10. \*$p\,\text{for}\,\text{interaction} < 0.1$; \*\*$p\,\text{for}\,\text{interaction} < 0.05$.](ehp-126-127006-g0002){#f2}

In the analyses of critical windows of susceptibility to Mn ([Figure 3](#f3){ref-type="fig"}), we observed that relative exposure levels of Mn for newborns who were in the 10th percentiles of birth weight, birth length, or ponderal index increased throughout the whole pregnancy, compared with those who were in the 90th percentiles, suggesting that the inverse association of urinary Mn concentrations with size at birth became stronger as the pregnancy progressed. In addition, for newborns who were born with a birth weight in the 10th percentile, compared with those in the 90th percentile, the relative exposure levels of Mn became significantly higher from 29 weeks of gestation. As of for birth length and ponderal index, relative exposure levels of Mn were significantly higher after 33 weeks and 14 weeks of gestation, respectively. Furthermore, when restricting the analysis to term births (see Figure S1) or women who provided three urine samples (see Figure S2), the observed exposure patterns of Mn were consistent with those observed in the whole population.

![Relative exposure levels of Mn comparing newborns with restricted size at birth to those without. Solid lines represent relative exposures of Mn through the whole pregnancy, comparing newborns in the 10th percentiles of (*A*) birth weight, (*B*) birth length, or (*C*) ponderal index to those in the 90th percentiles. Dotted lines represent pointwise 95% confidence intervals. Exposure patterns of Mn during pregnancy were estimated using linear mixed models with adjustment for gestational age at delivery, maternal age at recruitment, parity, prepregnancy body mass index, alcohol consumption before pregnancy, active smoking before pregnancy, passive smoking during pregnancy, education, folic acid supplementation, physical activity during pregnancy, and infant sex. The model for birth length model was additionally adjusted for maternal and paternal height.](ehp-126-127006-g0003){#f3}

Discussion {#s4}
==========

This prenatal cohort study investigated the trimester-specific associations of Mn exposure with size at birth in a large population of 3,022 women who were recruited in China. Based on repeated measurements of urinary Mn concentrations in the first, second, and third trimesters, we observed significant associations of elevated urinary Mn concentrations during pregnancy, especially in the second and third trimesters, with reductions in birth weight, birth length, and ponderal index. Moreover, newborns with restricted size at birth had relatively higher exposure levels of Mn in the second and third trimesters, especially during the late third trimesters.

In the study population, based on SG-adjusted urinary Mn concentrations, only 309 (5.1%) urine samples that were collected in different time periods exceeded the upper limit of the urinary reference for adults ($10\;\mu g/L$) ([@c38]). Urinary Mn concentrations of women in this study were lower than, but comparable to, those of pregnant women in a poor rural subdistrict in Bangladesh ([@c37]). However, urinary Mn concentrations of the study population were higher than that of the subpopulation in our previous study ([@c58]), of pregnant women from an agricultural community in California ([@c23]), and of nonsmoking pregnant women from Western Australia ([@c7]). Similarly, urinary Mn concentrations in the study population were relatively higher than those of adult men and nonpregnant women from different countries, including the United States ([@c8]), Canada ([@c26]), Japan ([@c41]), France ([@c21]), and Germany ([@c27]). The differences in urinary Mn concentrations across populations could be a result of different environmental exposure levels and dietary intakes. In addition, the Chinese population consumes more plant foods, which are main sources of dietary Mn, than the U.S. and European populations ([@c61]). Therefore, our findings should be interpreted and generalized with caution.

In this study, we observed that the ICC of urinary Mn concentrations indicated a poor reproducibility throughout the whole pregnancy. In addition, the median urinary Mn concentration in the third trimester was higher than that in the first and second trimesters, which was consistent with previous studies, suggesting Mn concentrations in maternal blood increases with the progression of gestation ([@c40]; [@c50]; [@c52]; [@c54]). Because fetal development may require additional amounts of Mn and lead to increased intestinal absorption or tissue Mn mobilization ([@c32]), which may result in late-pregnancy increases in urinary Mn concentrations, variations of Mn exposure levels during pregnancy, together with these physiological changes, could both contribute to the low reproducibility of urinary Mn concentrations throughout the whole pregnancy. Therefore, one time-point exposure estimation does not accurately represent Mn exposure levels in the whole gestation, and it is necessary to identify the window of heightened susceptibility to Mn for fetal growth. Because of the poor reproducibility of urinary Mn concentrations, it would cause potential misclassifications when using overall quintiles of urinary Mn concentrations to estimate the relationship between urinary Mn concentrations and size at birth. Therefore, we generalized trimester-specific quintiles for urinary Mn concentrations in each trimester. Furthermore, in order to reduce the influence of potential information bias caused by urine dilution, we used urinary SG instead of creatinine to adjust for urinary concentrations of Mn and other metals because urinary creatinine concentration increases as the pregnancy progresses due to physiological and anatomical changes in renal function for pregnant women ([@c11]).

We set medium quintiles of urinary Mn concentrations as reference groups in different time periods because the reference values of urinary or blood Mn concentrations during pregnancy have not been defined. Recent studies reported potential inverted U-shaped relationships between maternal blood Mn concentrations and birth weight ([@c9]; [@c19]; [@c62]). Another study from Dalian, China, observed a potential parabolic dose--response relationship between Mn concentrations in umbilical cord blood and birth weight ([@c22]). In addition to the above studies, our previous study also observed a potential U-shaped relationship between urinary Mn concentration and low birth weight risk ([@c58]). In this study, we also observed potential inverted U-shaped associations of urinary Mn concentrations in early, mid-, and late pregnancy with birth weight, birth length, and ponderal index: Higher maternal urinary Mn concentrations were related to stronger and more significant associations with reduced size at birth than lower concentrations.

Identifying critical windows of susceptibility to environmental pollutants exposure during pregnancy is essential for infants' and children's health because environmental exposures in such time windows could bring stronger impairment in children's growth and health ([@c46]; [@c48]). An animal study suggested that prenatal exposure to Mn was related to reduced fetal body weight and increased incidences of skeletal defects in mice, and exposures on days 9 and 10 of gestation (midpregnancy) had the strongest fetotoxicity ([@c12]). Another experimental study indicated that exposure to Mn from days 15 to 17 of gestation (late pregnancy) had the highest incidence of dose-dependent skeletal malformations in rats ([@c53]). To our knowledge, only two studies have investigated the trimester-specific associations of exposure to Mn with size at birth in humans, but the findings were inconsistent. One study, from Costa Rica ($n = 380$), observed linear associations of maternal hair Mn concentrations in the second and third trimesters with reduced chest circumference at birth ([@c40]). The other study, based on 76 women from Taiwan, suggested that Mn concentration in maternal erythrocytes in the first and second trimesters were linearly associated with reduced birth weight and neonatal head and chest circumferences ([@c54]). However, both studies were conducted with limited sample sizes and did not investigate the nonlinear associations. In this study, based on a large sample size of 3,022 women, we observed that urinary Mn concentrations in the second and third trimesters had stronger associations with reduced size at birth, which were consistent with those from animal studies and the study from Costa Rica ([@c40]). These findings suggest that mid and late trimesters may be critical windows of susceptibility to Mn exposure for fetal growth.

Dietary intake is the main source of Mn exposure for humans ([@c1]). A plant-based dietary pattern might be related to Mn exposure levels because rice, grains, soy beans, nuts, vegetables, fruits, and tea are rich in Mn ([@c61]). In animal studies, maternal exposure to high levels of Mn through oral administration resulted in reduced fetal weight, impaired skeleton ossification, and restricted internal organ development in offspring ([@c12]; [@c47]; [@c53]). On the other hand, Mn deficiency was also related to skeletal malformation and impaired growth in animals ([@c2]; [@c24]). Furthermore, exposure to high levels of Mn is capable of causing oxidative stress in cells and impairing the function and growth of cells ([@c17]). Moreover, Mn deficiency has been related to impairments or dysfunctions in lipoprotein metabolism, insulin production, oxidant defense system, and growth factor metabolism ([@c30]; [@c51]). These biological processes caused by either Mn overload or deficiency could be potential mechanisms of Mn-related impairments in fetal development and growth, but more studies are needed to investigate the underlying mechanisms.

Humans are exposed to different metals simultaneously, and the exposure levels of different metals are highly correlated. Additionally, some toxic metals (V, As, Cd, and Pb) have been related to restricted size at birth or increased risk of adverse birth outcomes ([@c10]; [@c29], [@c28]; [@c31]; [@c36]; [@c59]). In this study, we observed consistent associations after additionally adjusting for V, As, Cd, and Pb, suggesting that the observed associations between higher levels of Mn during pregnancy and restricted size at birth were not due to confounding by co-exposures to these metals. Moreover, results of sensitivity analyses evaluating the impacts of major confounders (premature deliveries and maternal pregnancy complications) and potential information bias (potential misclassifications caused by missing of urine samples, urine dilution, and urinary Mn concentrations variations) were consistent with the main results, suggesting robust relationships between urinary Mn concentrations and reduced size at birth in the study population.

The main strength of this study was the use of repeated measurements of urinary Mn concentrations in samples that were collected in the first, second, and third trimesters. Additionally, this study was carried out with a large sample size of 3,022 women who were recruited in a Chinese prenatal cohort. Information on outcomes (birth weight, birth length, and ponderal index) and potential confounders (e.g., demographic and socioeconomic characteristics, life-style factors, and gynecological and obstetrical information) was obtained via either medical records or in-person interviews. These advantages provided us the opportunity and enough statistical power to estimate both linear and nonlinear relationships between trimester-specific Mn exposure levels during pregnancy and size at birth. Moreover, because of these strengths, we were able to identify critical windows of susceptibility to Mn exposure during pregnancy that impaired fetal growth ([@c55]; [@c46]). Our findings could be generalizable to women in other Chinese cities.

One limitation of this study is that we estimated the Mn exposure levels during pregnancy using urinary concentrations. Mn in the human body is excreted primarily through feces because the human body eliminates Mn mainly through bile ([@c1]). In humans, urinary Mn excretion represents about 5% of the total excreted amount ([@c49]), and the half-life of urinary Mn is less than 30 h ([@c44]). We used repeatedly measured urinary Mn concentrations in samples collected over different time periods, which may be helpful in reducing the estimation errors caused by one-time measurement. Additional perspective cohort studies with larger sample sizes of women who have repeated measurement of urinary Mn concentrations, as well as studies conducted in other populations, are required to replicate the observed associations in this study. Another limitation of this study was the lack of systemic evaluation of nutritional conditions during pregnancy, which may influence the exposure and outcomes. We, therefore, cannot estimate the contribution and interaction of nutritional conditions during pregnancy on the association between prenatal exposure to Mn and size at birth. Future studies are needed to investigate the effects of mixtures of environmental pollutants (e.g., As, Cd, and Pb) and nutrients (e.g., copper, iron, and zinc) on fetal and childhood growth and development.

Conclusion {#s5}
==========

In this prospective prenatal cohort study, we observed that prenatal exposure to an elevated level of Mn was associated with significant reductions in birth weight, birth length, and ponderal index. In addition, the late period of pregnancy could be the critical window of heightened vulnerability to Mn exposure for fetal growth. Our findings suggest that high levels of Mn exposure during late pregnancy may be a risk factor for restricted size at birth, and may also be one of the risk factors for childhood and adulthood diseases that have been associated with restricted fetal growth. More studies from other populations and with larger sample sizes are required to replicate these observed associations.
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